Mixed responses to first-line alectinib in non-small cell lung cancer patients with rare ALK gene fusions: A case series and literature review.

Li, Mengnan; An, Zhou; Tang, Qiusu; Ma, Yutong; Yan, Junrong; Chen, Songan; Wang, Yina

Li, Mengnan; An, Zhou; Tang, Qiusu; Ma, Yutong; Yan, Junrong; Chen, Songan; Wang, Yina.

Affiliation

Li M; Department of Medical Oncology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
An Z; Department of Thoracic Surgery, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Tang Q; Department of Pathology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Ma Y; Nanjing Geneseeq Technology Inc., Nanjing, China.
Yan J; Nanjing Geneseeq Technology Inc., Nanjing, China.
Chen S; Burning Rock Biotech, Guangzhou, China.
Wang Y; Department of Medical Oncology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

J Cell Mol Med ; 25(19): 9476-9481, 2021 10.

Article de En | MEDLINE | ID: mdl-34541785

Sujet(s)
Mots clés

LMO7-ALK; STRN-ALK; NSCLC; alectinib; rare ALK fusion; survival

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pipéridines / Carbazoles / Protéines de fusion oncogènes / Carcinome pulmonaire non à petites cellules / Inhibiteurs de protéines kinases / Kinase du lymphome anaplasique / Tumeurs du poumon Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: J Cell Mol Med Sujet du journal: BIOLOGIA MOLECULAR Année: 2021 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google